The existence of intermediate CD4+ T cells from cluster 5 (CD3+CD4+CD45RO+CD7+CD158k+) in PB was further validated by FC in the SS patient, but not in the three HCs [32] (Fig S5B-C). Here, KIR3DL2 is linked to synovial sarcoma.